5 Insightful Analyst Questions From Centene’s Q1 Earnings Call

Centene’s first quarter results were met with a significant positive market reaction, reflecting stronger-than-expected operating performance across key business lines. Management attributed this to ongoing margin improvement in Medicaid, effective cost controls, and stabilized trends in high-cost areas such as behavioral health and specialty drugs. CEO Sarah London highlighted that a lighter flu season and favorable weather events contributed positively, while initiatives to modernize processes and combat fraud and waste continued to support financial results. The company also pointed to stronger-than-anticipated performance in its Medicare and Part D businesses, bolstered by better member retention and a favorable shift in risk scores.

Is now the time to buy CNC? Find out in our full research report (it’s free for active Edge members).

While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.

Our Top 5 Analyst Questions From Centene’s Q1 Earnings Call

• Andrew Mok (Barclays) asked about the reason for higher-acuity Silver tier membership and the potential margin impact if the full risk adjustment offset materializes. CEO Sarah London explained the post-subsidy market shift and stressed that risk adjustment is intended to counter adverse selection in Marketplace.
• Albert Rice (UBS) questioned whether Medicaid margin outperformance was mostly due to flu and weather or underlying improvements. London clarified that while these factors helped, “solid fundamental outperformance” from operational initiatives also contributed.
• Justin Lake (Wolfe Research) pressed on whether the risk adjustment receivable applied across all metal tiers or just Silver. London confirmed it covers the full book and that only a prudent portion of the potential offset was booked in guidance.
• Ann Hynes (Mizuho Securities) inquired about debt repayment strategy given upcoming maturities. CFO Drew Asher outlined plans to refinance or pay down debt, leveraging improved cash generation and potential further receivable sales.
• George Hill (Deutsche Bank) probed the impact of fraud, waste, and abuse initiatives on state rate negotiations. London acknowledged that addressing excessive utilization could eventually affect rates but maintained that these actions are aimed at ensuring appropriate care and long-term program integrity.

Catalysts in Upcoming Quarters

In the coming quarters, our analysts will closely monitor (1) the June Wakely risk adjustment data and its implications for Marketplace margins, (2) the effectiveness of Medicaid cost containment and fraud prevention initiatives as states roll out new work requirements and policy changes, and (3) continued progress in Medicare Advantage and PDP, especially in managing specialty drug costs. Updates on leadership execution and AI-driven analytics will also be key signposts for sustained margin recovery.

Centene currently trades at $53.47, up from $43.50 just before the earnings. Is the company at an inflection point that warrants a buy or sell? The answer lies in our full research report (it’s free).

The Best Stocks for High-Quality Investors

ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.

Our AI system flagged Palantir before it ran 1,662%. AppLovin before it ran 753%. Nvidia before it ran 1,178%. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today.